- Recommendation ID
- NG122/2
- Question
Stereotactic ablative radiotherapy compared with surgery: What is the effectiveness and cost effectiveness of stereotactic ablative radiotherapy (SABR) compared with surgery (for example, sublobar, wedge resection, lobectomy) for people with non-small-cell lung cancer (stage I and IIA) in whom surgery is suitable?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made the recommendation for research, see the rationale on surgery and radiotherapy with curative intent for non-small-cell lung cancer .
Full details of the evidence and the committee's discussion are in evidence review D: Radiotherapy with curative intent for NSCLC.
Source guidance details
- Comes from guidance
- Lung cancer: diagnosis and management
- Number
- NG122
- Date issued
- March 2019
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/03/2023 |